Lymphoma, T-Cell, Peripheral

• 

  Subject Areas on Research

  • A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. 
  • Composite lymphoma of follicular B-cell and peripheral T-cell types with distinct zone distribution in a 75-year-old male patient: a case study. 
  • NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. 
  • Peripheral T-cell lymphoma, NOS, and anaplastic large cell lymphoma. 
  • Primary cutaneous, composite, Epstein-Barr virus-associated, diffuse large B-cell lymphoma and peripheral T-cell lymphoma. 
  • Rare PTCLs: treatment lagging behind pathobiologic advances. 
  • Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901. 
  • The clinical significance of activated p-AKT expression in peripheral T-cell lymphoma. 
• 

  Keywords of People

  • Stefanovic, Alexandra, Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy